Abstract

Retrospective Study

Survival and predictors of mortality among HIV-infected adults receiving ART in Hawassa comprehensive specialized hospital, Sidama regional state, Ethiopia

Bargude Balta* and Amanuel Fanta

Published: 25 November, 2022 | Volume 5 - Issue 1 | Pages: 042-049

Background: Having claimed lives, HIV/AIDS is still a significant global public health concern. Antiretroviral therapy (ART) is now widely available, and this rapid expansion of access is dramatically improving HIV epidemic survival rates worldwide.
Objectives: The aim of this study was to identify the mortality risk factors and survival status of ART patients attending Hawassa Comprehensive Specialized Hospital in 2020.
Methods: In a five-year retrospective cohort research, all patients seen between January 2015 and December 2019 were analyzed. The data were analyzed with SPSS 25.0. The Kaplan-Meier Log-rank model was employed to gauge the survival time of ART patients based on explanatory variables. Both bivariate and multivariate Cox proportional hazards regression models were employed to identify the independent causes of mortality.
Results: Patients on ART had a 74% overall survival probability. With a median survival of 34 months, there are 0.135 deaths for every 100 person-years. Hemoglobin level (HR = 2.38; 95% CI = 3.3-6.3), WHO clinical stage III and IV (HR = 3; 95% CI = 2.2-9.5, p = 0.04), Age >=60 
(HR = 1.6; 95% CI = 1.3-2, p = 0.04) and Functional status bed ridden (HR = 3.1; 95% CI = 1.2-9.4,
p = 0.04) were all independent predictors of death among RVI patients.
Conclusion: In comparison to trials conducted in wealthy countries, the survival rate of ART patients in this study was low. Patients who are anemic; WHO advanced clinical stage; old age, and functional status bedridden should be closely followed and monitored.

Read Full Article HTML DOI: 10.29328/journal.japch.1001052 Cite this Article Read Full Article PDF

Keywords:

Antiretroviral therapy; Human immunodeficiency virus; Mortality; Survival; Ethiopia

References

  1. WHO fact sheet 2019. HIV/AIDS . HIV/AIDS. 2020. https://www.who.int/news-room/fact-sheets/detail/hiv-aids
  2. Poorolajal J, Hooshmand E, Mahjub H, Esmailnasab N, Jenabi E. Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis. Public Health. 2016;139:3-12. http://dx.doi.org/10.1016/j.puhe.2016.05.004
  3. Misgina KH, Weldu MG, Gebremariam TH, Weledehaweria NB, Alema HB, Gebregiorgis YS, Tilahun YG. Predictors of mortality among adult people living with HIV/AIDS on antiretroviral therapy at Suhul Hospital, Tigrai, Northern Ethiopia: a retrospective follow-up study. J Health Popul Nutr. 2019 Nov 29;38(1):37. doi: 10.1186/s41043-019-0194-0. PMID: 31783924; PMCID: PMC6883545.
  4. Dawood H, Hassan-Moosa R, Zuma NY, Naidoo K. Mortality and treatment response amongst HIV-infected patients 50 years and older accessing antiretroviral services in South Africa. BMC Infect Dis. 2018 Apr 10;18(1):168. doi: 10.1186/s12879-018-3083-z. PMID: 29636023; PMCID: PMC5894176.
  5. EFMOH: Ministry of Health Federal Democratic Republic of Ethiopia. National Guidelunes for comprehensive HIV Prevention, Care and Treatment. 2017;44–6.
  6. Mangal TD, Meireles MV, Pascom ARP, de Almeida Coelho R, Benzaken AS, Hallett TB. Determinants of survival of people living with HIV/AIDS on antiretroviral therapy in Brazil 2006-2015. BMC Infect Dis. 2019 Feb 28;19(1):206. doi: 10.1186/s12879-019-3844-3. PMID: 30819120; PMCID: PMC6396460.
  7. Onyango DO, Yuen CM, Cain KP, Ngari F, Masini EO, Borgdorff MW. Reduction of HIV-associated excess mortality by antiretroviral treatment among tuberculosis patients in Kenya. PLoS One. 2017 Nov 16;12(11):e0188235. doi: 10.1371/journal.pone.0188235. PMID: 29145454; PMCID: PMC5690617.
  8. Seyoum D, Degryse JM, Kifle YG, Taye A, Tadesse M, Birlie B, Banbeta A, Rosas-Aguirre A, Duchateau L, Speybroeck N. Risk Factors for Mortality among Adult HIV/AIDS Patients Following Antiretroviral Therapy in Southwestern Ethiopia: An Assessment through Survival Models. Int J Environ Res Public Health. 2017 Mar 12;14(3):296. doi: 10.3390/ijerph14030296. PMID: 28287498; PMCID: PMC5369132.
  9. Assebe LF, Reda HL, Wubeneh AD, Lerebo WT, Lambert SM. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study. BMC Public Health. 2015 Apr 10;15:346. doi: 10.1186/s12889-015-1719-0. PMID: 25886730; PMCID: PMC4394593.
  10. Tiruneh G, Getahun A, Adeba E. Assessing the Impact of Isoniazid Preventive Therapy (IPT) on Tuberculosis Incidence and Predictors of Tuberculosis among Adult Patients Enrolled on ART in Nekemte Town, Western Ethiopia: A Retrospective Cohort Study. Interdiscip Perspect Infect Dis. 2019 May 2;2019:1413427. doi: 10.1155/2019/1413427. PMID: 31186628; PMCID: PMC6521313.
  11. Yiannoutsos CT, Johnson LF, Boulle A, Musick BS, Gsponer T, Balestre E, Law M, Shepherd BE, Egger M; International Epidemiologic Databases to Evaluate AIDS (IeDEA) Collaboration. Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy. Sex Transm Infect. 2012 Dec;88 Suppl 2(Suppl_2):i33-43. doi: 10.1136/sextrans-2012-050658. PMID: 23172344; PMCID: PMC3512431.
  12. Damtew B, Mengistie B, Alemayehu T. Survival and determinants of mortality in adult HIV/Aids patients initiating antiretroviral therapy in Somali Region, Eastern Ethiopia. Pan Afr Med J. 2015;22:1–8.
  13. Kee MK, Lee JH, Kim EJ, Lee J, Nam JG, Yoo BH, Kim SS. Improvement in survival among HIV-infected individuals in the Republic of Korea: need for an early HIV diagnosis. BMC Infect Dis. 2009 Aug 12;9:128. doi: 10.1186/1471-2334-9-128. PMID: 19671189; PMCID: PMC2738677.
  14. Pavlova-McCalla E, Trepka MJ, Ramirez G, Niyonsenga T. Socioeconomic Status and Survival of People with Human Immunodeficiency Virus Infection before and after the Introduction of Highly Active Antiretroviral Therapy: A Systematic Literature Review. J AIDS Clin Res. 2012 Jul 20;3(6):1000163. doi: 10.4172/2155-6113.1000163. PMID: 24575328; PMCID: PMC3933225.
  15. Mageda K, Leyna GH, Mmbaga EJ. High Initial HIV/AIDS-Related Mortality and -Its Predictors among Patients on Antiretroviral Therapy in the Kagera Region of Tanzania: A Five-Year Retrospective Cohort Study. AIDS Res Treat. 2012;2012:843598. doi: 10.1155/2012/843598. Epub 2012 Sep 2. PMID: 22973505; PMCID: PMC3437609.
  16. Sieleunou I, Souleymanou M, Schönenberger AM, Menten J, Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health. 2009 Jan;14(1):36-43. doi: 10.1111/j.1365-3156.2008.02183.x. Epub 2008 Nov 12. PMID: 19017309.
  17. Dias, Vera Junn, Eunsung Mouradian MM. Genetic alterations. NIH Public Access. Bone. 2008;23(1):1–7.
  18. Tadesse K, Haile F, Hiruy N. Predictors of mortality among patients enrolled on antiretroviral therapy in Aksum hospital, northern Ethiopia: a retrospective cohort study. PLoS One. 2014 Jan 31;9(1):e87392. doi: 10.1371/journal.pone.0087392. PMID: 24498093; PMCID: PMC3909114.
  19. Ayele W, Mulugeta A, Desta A, Rabito FA. Treatment outcomes and their determinants in HIV patients on Anti-retroviral Treatment Program in selected health facilities of Kembata and Hadiya zones , Southern Nations , Nationalities and Peoples Region , Ethiopia. BMC Public Health . 2015;1–13. http://dx.doi.org/10.1186/s12889-015-2176-5
  20. Wondimu W, Dube L, Kabeta T. Factors Affecting Survival Rates Among Adult TB/HIV Co-Infected Patients in Mizan Tepi University Teaching Hospital, South West Ethiopia. HIV AIDS (Auckl). 2020 Apr 23;12:157-164. doi: 10.2147/HIV.S242756. PMID: 32368156; PMCID: PMC7185339.
  21. Regional O, Forschen S. Determinants of Survival among Adults on Antiretroviral Therapy in Adama Hospital Medical. 2016.
  22. Tachbele E, Ameni G. Survival and predictors of mortality among human immunodeficiency virus patients on anti-retroviral treatment at Jinka Hospital, South Omo, Ethiopia: a six years retrospective cohort study. Epidemiol Health. 2016 Nov 6;38:e2016049. doi: 10.4178/epih.e2016049. PMID: 27820957; PMCID: PMC5309728.
  23. Joseph N, Sinha U, Tiwari N, Ghosh P, Sindhu P. Prognostic Factors of Mortality among Adult Patients on Antiretroviral Therapy in India: A Hospital Based Retrospective Cohort Study. Biomed Res Int. 2019 Jan 21;2019:1419604. doi: 10.1155/2019/1419604. PMID: 30805359; PMCID: PMC6363333.
  24. Zhang G, Gong Y, Wang Q, Deng L, Zhang S, Liao Q, Yu G, Wang K, Wang J, Ye S, Liu Z. Outcomes and factors associated with survival of patients with HIV/AIDS initiating antiretroviral treatment in Liangshan Prefecture, southwest of China: A retrospective cohort study from 2005 to 2013. Medicine (Baltimore). 2016 Jul;95(27):e3969. doi: 10.1097/MD.0000000000003969. PMID: 27399071; PMCID: PMC5058800.
  25. FMOH Ethiopia. National Consolidated Guidelines for Comprehensive Hiv Prevention , Care and. FMOH 2018;1–238. Available from: file:///C:/Users/Tere/Desktop/University of South Africa (17-2017)/Documents on Cervical Cancer/July 22,2017/All Litratures/National Comprehensive HIV Care Guideline 2018.pdf.
  26. Alemu AW, Sebastián MS. Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. Glob Health Action. 2010 Oct 29;3. doi: 10.3402/gha.v3i0.5398. PMID: 21042435; PMCID: PMC2967337.
  27. Beshir MT, Beyene AH, Tlaye KG, Demelew TM. Incidence and predictors of tuberculosis among HIV-positive children at Adama Referral Hospital and Medical College, Oromia, Ethiopia: a retrospective follow-up study. Epidemiol Health. 2019;41:e2019028. doi: 10.4178/epih.e2019028. Epub 2019 Jun 22. PMID: 31319659; PMCID: PMC6702120.
  28. Tchounga B, Ekouevi DK, Balestre E, Dabis F. Mortality and survival patterns of people living with HIV-2. Curr Opin HIV AIDS. 2016 Sep;11(5):537-544. doi: 10.1097/COH.0000000000000299. PMID: 27254747; PMCID: PMC5055442.
  29. Gupta A, Nadkarni G, Yang WT, Chandrasekhar A, Gupte N, Bisson GP, Hosseinipour M, Gummadi N. Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis. PLoS One. 2011;6(12):e28691. doi: 10.1371/journal.pone.0028691. Epub 2011 Dec 29. PMID: 22220193; PMCID: PMC3248405.

Figures:

Figure 1

Figure 1

Figure 1

Figure 2

Similar Articles

Recently Viewed

Read More

Most Viewed

Read More

Help ?